Gastroesophageal Reflux Syndrome

 Gastroesophageal Reflux Syndrome
 
Controlling Gerd
Analogy For Antacids Neutralizing Acids
Risk Of Aspiration With Gerd
Gastroesophageal Sphincter
Gastroesophageal Flap Valve Hill Classification
Gastroesophageal Disease
Holisitic Cure For Acid Reflux
Achalasia Treatment
Foods To Eat Acid Reflux
Acid Reflux In Kids
Menstrual Cycles And Acid Reflux
Symptoms Of Non Ulcer Dyspepsia
Formula For Stomach Acid
Indigestion Raw Onions Cause
Acid Reflux Heartburn During Pregnancy
Gallbladder And Gerd
Acid Reflux And Walnuts
Acid Feeling In My Stomach
Acid Reflux Recipe
Swapping airport for rails not a done deal

The sailing won't be altogether smooth in the King County Council for an ambitious plan to swap county-owned Boeing Field to the Port of Seattle for an Eastside rails-to-trail corridor, council members say.

The tensions provoked by the proposal, which was announced in October by County Executive Ron Sims and port Chief Executive Mic Dinsmore, are reminiscent of the squabbling over Sims' 2006 plan to lure Southwest Airlines to Boeing Field from Sea-Tac Airport, which is operated by the port. That idea crashed and burned because of fierce opposition on the council, in the community and from the port.

This time around, the port is on board. In fact, Sims' chief of staff, Kurt Triplett, said the new proposal was born of an effort to smooth county-port relations after the Southwest dust-up.


Strong Start for Axcan Pharma's Fiscal 2007, With Record Revenue of $78.8 Million in the First Quarter

Axcan Pharma Inc. (TSX: AXP)(NASDAQ: AXCA) - today reported financial results for the first quarter of fiscal 2007, ended December 31, 2006 (all amounts are stated in U.S. dollars). Highlights for the quarter include:

- Revenue of $78.8 million, an increase of 11.6% compared to the first quarter of fiscal 2006

- Diluted income per share for the first quarter of 2007 amounted to $0.34, compared to diluted income per share of $0.19 a year earlier, a 78.9% increase

- Revenue guidance for fiscal 2007 increased to $307- $312 million

"We are pleased to report very strong performance for this first quarter with double-digit revenue and income growth, led by our strong base business and solid prescription growth for all our key products in both North America and Europe," stated Frank Verwiel, M.D., President and Chief Executive Officer of Axcan.


HubCap: Please describe your symptoms

One of the gifts my father gave me this past Christmas was the most vicious head cold I've had since I was old enough to tough it out and go to work anyway. I pride myself on the fact that I never get sick. Never. But this one, which I got on my day off, thank you, knocked me out for almost a week. Two days at home, lying around trying to read books or watch a full movie didn't help. What helped was five consecutive nights of 11 hours of sleep or more. Incredible. Then the coughing started, of course, and the snot began draining everywhere. Yes, Mom, I did get my flu shot this year. Unfortnately, whatever Dad gave me on my visit to Iowa was some sort of mutant virus that could probably bring the death of a civilization of people with unevolved immune systems. To the folks on my flight from Des Moines to Denver, I'm sorry.



 

 

 

Link to us  - Contact us